Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Post-Close Trading Update

24 Jan 2019 07:00

RNS Number : 9311N
Medica Group PLC
24 January 2019
 

24 January 2019

Medica Group Plc

 

Post-Close Trading Update

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, announces a post-close period trading update for the year ended 31 December 2018.

 

The Company has achieved revenue for the year of £39.0m, an increase of 15.6% year on year, driven by increased demand for NightHawk and Cross-Sectional services, in line with the Company's strategy. The Company also expects to maintain the EBITDA margin of around 30% as seen at the H1 report. The Board expects the Company's performance for 2018 to be in line with market expectations.

 

The total number of contracted radiologists (including radiographers and rheumatologists) as at 31 December 2018 was 362 radiologists (31 December 2017: 306).

 

John Graham, Chief Executive Officer of Medica, commented:

 

"In 2018, Medica continued to deliver double-digit revenue growth as we execute our strategy to increase customer penetration of our NightHawk and Cross Sectional services. Additionally, during 2018 we continued to generate cash and had zero net debt at the year-end.

 

The combination of our market leading platform, strong cohort of radiologists and our reputation for high quality clinical governance means that Medica is well positioned to help our customers meet their requirements for teleradiology services.

 

In 2019 we expect that the business will continue to grow at a similar rate to that seen in 2018 giving us confidence to increase investment to support future growth opportunities."

 

Medica will publish final statutory results for the year ended 31 December 2018 on 25 March 2019.

 

-ENDS-

 

For further details contact:

 

Medica Group:

+44 (0)33 33 111 222

John Graham, Chief Executive Officer

Tony Lee, Chief Financial Officer

FTI Consulting

+44 (0)20 3727 1000

Brett Pollard

Ben Atwell

Robert Winder

 

 

About Medica

 

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

 

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk

 

About teleradiology

 

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUORBRKUAAUAR
Date   Source Headline
14th May 202012:35 pmRNSDirector/PDMR Shareholding
14th May 202012:35 pmRNSDirector/PDMR Shareholding
14th May 202012:35 pmRNSDirector/PDMR Shareholding
20th Apr 202012:58 pmRNSPosting of Annual Report and Notice of AGM
16th Apr 20203:45 pmRNSDirector/PDMR Shareholding
16th Apr 20203:45 pmRNSDirector/PDMR Shareholding
16th Apr 20203:45 pmRNSDirector/PDMR Shareholding
9th Apr 20204:12 pmRNSDirector/PDMR Shareholding
9th Apr 20204:08 pmRNSDirector/PDMR Shareholding
9th Apr 20202:00 pmRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
7th Apr 20207:00 amRNSPreliminary results: continued double-digit growth
6th Apr 20207:00 amRNSNon-Executive Director Change
2nd Apr 20207:00 amRNSNotice of preliminary results
30th Mar 20207:00 amRNSAppointment of Chief Financial Officer
23rd Mar 20207:00 amRNSMedica Group: Market and Trading Update
23rd Mar 20207:00 amRNSMedica and Qure.ai partner to use AI
18th Mar 20207:22 amRNSAppointment of Clinical Director - Replacement
18th Mar 20207:00 amRNSAppointment of Clinical Director
12th Mar 20204:39 pmRNSPrice Monitoring Extension
11th Mar 20207:00 amRNSDirectorate Change
6th Mar 20209:27 amRNSNotification of Major Holdings
18th Feb 20204:41 pmRNSSecond Price Monitoring Extn
18th Feb 20204:35 pmRNSPrice Monitoring Extension
31st Jan 20209:49 amRNSNotification of Major Holdings
24th Jan 202011:20 amRNSNotification of Major Holding
24th Jan 202010:59 amRNSNotification of Major Holdings
23rd Jan 20207:00 amRNSPre-Close Trading Update
23rd Oct 201911:07 amRNSHolding(s) in Company
23rd Oct 201911:06 amRNSHolding(s) in Company
9th Oct 201912:02 pmRNSPrice Monitoring Extension
1st Oct 20194:41 pmRNSSecond Price Monitoring Extn
1st Oct 20194:35 pmRNSPrice Monitoring Extension
30th Sep 20194:41 pmRNSSecond Price Monitoring Extn
30th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20198:24 amRNSDirector/PDMR Shareholding
9th Sep 20197:00 amRNSInterim results demonstrate strong performance
2nd Sep 20197:00 amRNSDirectorate Change
13th Aug 201912:07 pmRNSSecond Price Monitoring Extn
13th Aug 201912:02 pmRNSPrice Monitoring Extension
26th Jul 201912:07 pmRNSSecond Price Monitoring Extn
26th Jul 201912:02 pmRNSPrice Monitoring Extension
25th Jul 20197:00 amRNSPre-Close Trading Update
24th Jul 20194:41 pmRNSSecond Price Monitoring Extn
24th Jul 20194:35 pmRNSPrice Monitoring Extension
24th Jul 201912:07 pmRNSSecond Price Monitoring Extn
24th Jul 201912:02 pmRNSPrice Monitoring Extension
23rd Jul 201912:07 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.